NCT01139190View on ClinicalTrials.gov

Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

77

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Gastroduodenal UlcerationsErosion

Interventions

DRUG

PL3100

Oral administration

DRUG

Naproxen

Oral administration

Trial Locations (2)

75216

Dallas VA Medical Center, Dallas

77074

Houston Center For Clinical Research, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

PLx Pharma

INDUSTRY